Medical
Biotechnology
Biopharmaceutical
Amgen
$177.479876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$177.47
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$1.35 (0.77%) Today
$0.00 (0.00%) As of 4:33 PM EDT after-hours
Why Robinhood?
You can buy or sell Amgen and other stocks, options, ETFs, and crypto commission-free!
About AMGN
Amgen Inc. Common Stock, also called Amgen, is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Read More Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Employees
21,500
Headquarters
Thousand Oaks, California
Founded
1980
Market Cap
108.21B
Price-Earnings Ratio
14.15
Dividend Yield
2.71
Average Volume
2.87M
High Today
$177.77
Low Today
$175.92
Open Price
$176.34
Volume
2.16M
52 Week High
$210.19
52 Week Low
$166.30
Collections
Medical
Biotechnology
Biopharmaceutical
Health
Cancer Prevention
Pharmaceutical
Therapy
Manufacturing
AMGN News
Price Paid on Robinhood
1% Lower
Right Now
52 Week Low
$165.22
Average Price Paid
$179.36
52 Week High
$210.19
Analyst Ratings
52%
of 23 ratings
Buy
52%
Hold
48%
Sell
0%
AMGN Earnings
$2.89
$3.20
$3.52
$3.83
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Available Jul 30, After Hours